Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:04 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1681–1704 of 3,872 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: FAST Clear all

Conditions: Healthy
Interventions: Zonisamide, Zonegran; Drug
Lead sponsor: Dr. Reddy's Laboratories Limited; Industry
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005
U.S. locations: 1
States / cities: Fort Myers, Florida

Conditions: Atrial Fibrillation, Heart Failure
Interventions: ASSERT Insertable Cardiac Monitor, Conventional Management and monitoring; Device · Other
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 477 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Diabetes Mellitus, Cardiovascular Diseases
Interventions: Intensive Glucose Management, Traditional Glucose Management:; Behavioral
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 35 Years and older
Enrollment: 133 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Healthy Participants
Interventions: Zibotentan/Dapagliflozin FDC; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Glendale, California

Conditions: HCV Infection
Interventions: placebo, GS-9190, Peginterferon Alfa 2a, Ribavirin; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 252 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 48
States / cities: Anaheim, California • Los Angeles, California • Newport Beach, California + 37 more

Conditions: Respiratory Viruses
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 12 Years to 99 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Alzheimer's Disease; Dementia
Interventions: HIGH and LOW meal ingestion; Other
Lead sponsor: University of Washington; Other
Eligibility: 55 Years and older
Enrollment: 78 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Time Restricted Eating, Eating Behavior, Diet, Healthy, Nutrition, Healthy
Interventions: Time restricted eating; Behavioral
Lead sponsor: University of Delaware; Other
Eligibility: 20 Years to 29 Years
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: PTSD, Posttraumatic Stress Disorder
Interventions: Ketamine, Placebo/Saline; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 70 Years
Enrollment: 163 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 3
States / cities: West Haven, Connecticut • Minneapolis, Minnesota • San Antonio, Texas

Conditions: Obesity
Interventions: Condition A (see detailed summary), Condition B (see detailed summary), Condition C (see detailed summary); Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 13 Years to 17 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: GDM, Lactation
Interventions: Hyperinsulinemic-euglycemic clamp; Diagnostic Test
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: HIV Infections
Interventions: Non-targeted opt-out rapid HIV screening; Other
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 16 Years and older
Enrollment: 120,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Rheumatoid Arthritis
Interventions: Non-interventional; Other
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 265 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 7
States / cities: Beverly Hills, California • Gainesville, Georgia • Coeur d'Alene, Idaho + 4 more

Conditions: To Determine the Bioavailability of Tranylcypromine
Interventions: Tranylcypromine, Parnate; Drug
Lead sponsor: Par Pharmaceutical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004
U.S. locations: 1
States / cities: Fort Myers, Florida

Conditions: Healthy
Interventions: Crizotinib, Esomeprazole; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Cardiometabolic Risk Factors in Adult Wheelchair Users
Interventions: Instructor-led, one-on-one M2M exercise group, Self-guided control with pre-recorded standard exercise videos; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 89 Years
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Dry Skin
Interventions: AmLactin® Rapid Relief; Other
Lead sponsor: Sandoz; Industry
Eligibility: 50 Years and older · Female only
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: High Point, North Carolina

Conditions: Diabetes Mellitus
Interventions: Humalog, Humulin-R, Recombinant human hyaluronidase PH20 (rHuPH20); Drug
Lead sponsor: Halozyme Therapeutics; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Healthy
Interventions: Alendronate Sodium Tablets, 70 mg, Fosamax Tablets, 70 mg; Drug
Lead sponsor: Mylan Pharmaceuticals Inc; Industry
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002
U.S. locations: 1
States / cities: Fargo, North Dakota

Conditions: Type 2 Diabetes Mellitus
Interventions: CGMS with an insulin pump using rapid acting insulin; Device
Lead sponsor: Diabetes Care Center; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Salinas, California

Conditions: Eating Disorders, Anorexia Nervosa, Bulimia Nervosa, Binge Eating Disorder, Other Specified Feeding or Eating Disorder
Interventions: Eating Disorder Dynamic Intervention; Behavioral
Lead sponsor: Trustees of Dartmouth College; Other
Eligibility: 18 Years to 70 Years
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: HIV
Interventions: Reducing Risk Behavior, Support and Guidance; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 24 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Breast Cancer
Interventions: Saturated Fat Meal, Oleic Sunflower Oil Meal; Other
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: Female only
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Food Choices
Interventions: Control (QR Code) Menu Labels, Traffic-Light Style Environmental Harm Menu Labels; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years to 64 Years
Enrollment: 450 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions

Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients

Improving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery

A Study to Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without Food

Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection

Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples

APOE Genotype and Diet Influences on Alzheimer's Biomarkers

Time Restricted Eating, Eating Behaviors, and Cardiometabolic Risk in Emerging Adult Women

CAP-Ketamine for Antidepressant Resistant PTSD

Fast Food Feeding in Youth

The Effect of Lactation on Insulin Sensitivity and Lipolysis in Women

Evaluation of Opt-Out Rapid HIV Testing in the Emergency Department

The Value of Orencia in Rapidly Progressing Rheumatoid Arthritis

Bioavailability Study of Tranylcypromine 10mg Tablets Under Fasting Conditions

A Study to Evaluate the Effects of Food and Esomeprazole on the Pharmacokinetics of Crizotinib in a Coated Microsphere Formulation.

Cardiometabolic Health Intervention Using Movement-to-Music Exercise

This Was a Clinical Study Investigating the Moisturization and Desquamation Effect of AmLactin® Rapid Relief Restoring Lotion + Ceramides on Dry Skin in Healthy Female Volunteers. AmLactin® Rapid Relief is an Over-the-counter Cosmetic

Pharmacokinetic (PK), Pharmacodynamic (PD), and Safety Study of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin-R® With and Without rHuPH20

Fasting Study of Alendronate Sodium Tablets (70 mg) and Fosamax Tablets (70 mg)

Diabetes Mellitus Type 2 Basal Insulin Dosing Requirements Study

Eating Disorder Dynamic Intervention

The Georgia Latino AIDS/HIV Diagnosis and Linkage in Youth (GLADLY) Project

Fast Food, Fatigue, and Inflammation

Environmental Harm Menu Labels and the Healthfulness of Real-World Fast-Food Orders